Consequences of chromsome18q deletions

Area of Science:

• Genetics
• Molecular Biology
• Clinical Genetics

Background:

• Chromosome 18q deletion exhibits significant heterogeneity, with variable hemizygous regions affecting 1-101 genes.
• Over 350 individuals analyzed revealed that 23% have interstitial deletions, complicating prognosis and treatment.
• Understanding the clinical impact of each gene on chromosome 18q is crucial due to this variability.

Purpose of the Study:

• To approach the complexity of chromosome 18q deletions by analyzing gene dosage effects individually.
• To correlate specific gene haploinsufficiency or conditional haploinsufficiency with observed phenotypes.
• To establish a foundation for compiling individualized syndrome descriptions based on genotype.

Main Methods:

• Systematic gene-by-gene analysis of 196 genes located on chromosome 18q.
• Classification of genes based on dosage sensitivity: insensitive, haploinsufficient, or conditionally haploinsufficient.
• Phenotypic data collection and correlation with specific gene deletions or critical regions.

Main Results:

• 133 genes on 18q were classified as dosage insensitive.
• 15 genes (8%) demonstrated dosage sensitivity leading to haploinsufficiency.
• 10 genes (5%) were conditionally haploinsufficient, and 37 genes (19%) had insufficient data for classification. Numerous phenotypes were linked to single genes or critical regions.

Conclusions:

• A gene-by-gene approach is feasible for understanding chromosome 18q deletion phenotypes.
• Individualized genotype-phenotype correlations are becoming increasingly possible.
• Future research will focus on molecular mechanisms to guide treatment strategies for chromosome 18q deletion.